FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important of the HER-2/ErbB2 Oncogene

被引：6
|
作者：
Zuo, Tao
Wang, Lizhong
Morrison, Carl
Chang, Xing
Zhang, Huiming
Li, Weiquan
Liu, Yan
Wang, Yin
Liu, Xingluo
Chan, Michael W. Y.
Liu, Jin-Qing
Love, Richard
Liu, Chang-Gong
Godfrey, Virginia
Shen, Rulong
Huang, Tim H-M
Yang, Tianyu
Park, Bae Keun
Wang, Cun-Yu
Zheng, Pan
Liu, Yang
机构：
来源：
CELL | 2021年 / 184卷 / 26期
关键词：
D O I：
10.1016/j.cell.2021.11.030
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：1275 / 1275
页数：1
相关论文
共 50 条
  • [31] HER-2/neu oncogene amplification in breast cancer.
    Depowski, PL
    Brien, TP
    Sheehan, CE
    Muraca, PJ
    Stylos, S
    Johnson, RL
    Ross, JS
    LABORATORY INVESTIGATION, 1998, 78 (01) : 18A - 18A
  • [32] Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment
    Helen C Hurst
    Breast Cancer Research, 3
  • [33] Update on HER-2 as a target for cancer therapy -: The ERBB2 promoter and its exploitation for cancer treatment
    Hurst, HC
    BREAST CANCER RESEARCH, 2001, 3 (06) : 395 - 398
  • [34] IMMUNOHISTOCHEMICAL DEMONSTRATION OF THE C-ERBB-2 HER-2 ONCOGENE IN HUMAN-BREAST CARCINOMAS
    GUSTERSON, BA
    GULLICK, WJ
    VENTER, DJ
    HARRISON, S
    ELLIOTT, C
    BREAST CANCER RESEARCH AND TREATMENT, 1987, 10 (01) : 121 - 121
  • [35] Simultaneous amplification of Topoisomerase II alpha (TOP2A) and HER-2 (ERBB2) is rare in select patients with breast cancer
    Primeaux, T. M.
    Martin, S.
    Nordberg, M. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 687 - 687
  • [36] Expression and gene copy number analysis of ERBB2 oncogene in prostate cancer
    Savinainen, KJ
    Saramäki, OR
    Linja, MJ
    Bratt, O
    Tammela, TLJ
    Isola, JJ
    Visakorpi, T
    AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (01): : 339 - 345
  • [37] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Harari, D
    Yarden, Y
    ONCOGENE, 2000, 19 (53) : 6102 - 6114
  • [38] A modified approach for I-FISH evaluation of ERBB2 (HER-2) gene copy numbers in breast carcinomas: comparison with HER-2/CEP17 ratio system
    Marcela Mrhalova
    Roman Kodet
    Journal of Cancer Research and Clinical Oncology, 2007, 133 : 321 - 329
  • [39] Future options in the treatment of ErbB2 (HER2)-positive breast cancer
    Fumoleau, Pierre
    EJC SUPPLEMENTS, 2008, 6 (05): : 25 - 31
  • [40] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Daniel Harari
    Yosef Yarden
    Oncogene, 2000, 19 : 6102 - 6114
12345